Lemnisca, a Bio AI company developing intelligent systems to support and scale biomanufacturing, has raised an undisclosed amount in a pre-seed funding round led by Theia Ventures.
This round also saw participation from PointOne Capital and Dr Satakarni Makkapati.
The funds raised will be used to strengthen its Bengaluru lab, AI platform development, and early pilots to scale sustainable bioproduction.
Founded in 2025 by Pushkar Pendse and Shilpa Nargund, Lemnisca is building an AI companion for fermentation that helps manufacturers scale bioprocesses faster, more predictably, and with greater efficiency.
Lemnisca’s science-aware AI works alongside scientists and operators, coupling wet-lab experimentation with dry-lab modelling to understand process biology and steer production in real time.
Lemnisca will initially partner with fermentation-led manufacturers already advancing along their biomanufacturing journey, while also building its own internal product pipeline.
The company aims to reduce development timelines by up to 50%, improve operating efficiency by 25%, and accelerate the adoption of renewable and waste-carbon feedstocks, ensuring rapid validation and scalable impact.
The company is currently inviting pilot collaborations and strategic partnerships across CDMOs, OEMs/SIs, and global ingredient brands.
Pushkar Pendse, Co-founder & CEO, Lemnisca, said, “From day one, our question was simple: how do we make biomanufacturing the default manufacturing mode globally? Our focus is to build the digital operating system that brings biology from lab to factory, making scale-up faster, smarter, and globally accessible.”
Shilpa Nargund, Co-founder & CTO, Lemnisca, said, “We are rethinking everything, right from lab workflows to model architectures. The goal is fewer surprises at scale and faster, repeatable success.”
Priya Shah, Partner at Theia Ventures, said, “We are delighted to be early partners in Lemnisca’s journey, where we firmly believe that biomanufacturing in today’s era needs advanced digital simulators that predict how microbial processes will perform before reaching large industrial scale. The team brings rich practical experience to support the symbiotic development of this product to be applied to nutraceutical markets.”
This is Theia Ventures’ third investment from its new fund, which announced its first close anchored by British International Investment last month. The fund counts Sarla Aviation (an electric aircraft company) and Climitra Carbon (a biochar company catering to the steel industry) as its first two investments, and the fund has committed to three additional investments to be deployed within this financial year.
